PRESS RELEASE – ENS HSC Briefing Paper | Unlocking the Potential of Radiopharmaceuticals in Europe – Part 1: Setting the Scene

PRESS RELEASE ENS High Scientific Council Briefing Paper Unlocking the Potential of Radiopharmaceuticals in Europe – Part 1: Setting the Scene Brussels, 18th March 2026 — The European Nuclear Society High Scientific Council (HSC) has published a new Briefing Paper titled “Unlocking the Potential of Radiopharmaceuticals in Europe – Part 1: Setting the Scene”, providing…

Framatome Strengthens Partnerships to Support Nuclear Fuel Supply and SMR Deployment in Europe

Framatome Strengthens Partnerships to Support Nuclear Fuel Supply and SMR Deployment in Europe Last week, Framatome (ENS Corporate Member) signed a new contract with the Belgian Nuclear Research Centre, SCK CEN (ENS Corporate Member), to supply high‑density silicide low‑enriched uranium (HD LEU) fuel elements for the BR2 research reactor in Belgium. The BR2 reactor is…

Studsvik Joins ENS As A New Corporate Member

Studsvik Joins ENS As A New Corporate Member Following the approval of the ENS General Assembly, we are glad to announce that Studsvik has joined the European Nuclear Society as a new Corporate Member, effective 30th March 2026. Studsvik Studsvik is a Swedish company providing advanced technical services and solutions to the global nuclear industry. With over…

EPRI Framatome

Framatome Demonstrates Ultrasonic Inspection Capability for PWR Core Barrel Welds with EPRI Documentation

Framatome Demonstrates Ultrasonic Inspection Capability for PWR Core Barrel Welds with EPRI Documentation Framatome (ENS Corporate Member) has demonstrated an ultrasonic inspection technique for weld examinations on pressurised water reactor (PWR) core barrels, with EPRI (ENS Corporate Member) documenting the demonstrated capability. The demonstrated capability supports enhanced inspection practices for PWR reactor internals and contributes…

Radiopharmaceuticals

PRESS RELEASE – ENS HSC Position Paper | Unlocking the Potential of Radiopharmaceuticals in Europe – Part 2: Strategic Challenges and Policy Priorities

PRESS RELEASE ENS High Scientific Council Position Paper Unlocking the Potential of Radiopharmaceuticals in Europe Part 2: Strategic Challenges and Policy Priorities Brussels, 15th April 2026 — The European Nuclear Society High Scientific Council (HSC) has published a new Position Paper titled “Unlocking the Potential of Radiopharmaceuticals in Europe – Part 2: Strategic Challenges and…